Sistemska skleroza koja se javila u pacijentice s malignim melanomom, a pod terapijom nivolumabom- paraneoplastična manifestacija ili nuspojava imunoterapije?

Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?